Delving into the Latest Updates on Guangdong Wellen Biological Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Hemic and Lymphatic Diseases

Congenital Disorders

Other Diseases

Interleukins

Non-recombinant coagulation factor

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	2

Top 5 Drug Type	Count

Non-recombinant coagulation factor	1
Interleukins	1

Top 5 Target	Count

F10 x factor IX x factor VII x thrombin	1
IL-2R(Interleukin-2 receptor)	1

An HPLC method was established for determination of amino acids in human prothrombin complex.Each kind of amino acids reacted with 6-aminoquinolyl-N-hydroxysuccinimdyl-carbamate (AQC) resp., and their corresponding derivatives were analyzed and quantified by the Agilent 1200 HPLC using AccQ-Tag C₁₈ column (waters 150 mm×3.9 mm, 4 μm) for gradient elution, with the mobile phase of water, eluent diluent (acetic acid salt-phosphate buffer) and acetonitrile at a wavelength of 248 nm by UV-detector, the column temperature was set at 37°C, and the sample volume was 10 μL.The amino acids were completely determined in 32 min, the recoveries were 99.3%-100.6%, and RSD was less than 1.5%.The method is simple, accurate and suitable for the determination of amino acids in human prothrombin complex.

100 Deals associated with Guangdong Wellen Biological Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Guangdong Wellen Biological Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

2

1

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Human Prothrombin Complex (Guangdong Wellen Biological Pharmaceutical) ( F10 x factor IX x factor VII x thrombin )	Hemophilia B More	Approved
Recombinant human interleukin-2 (rhIL-2)(Guangdong Wellen Biological Pharmaceutical Co. Ltd.) ( IL-2R )	Thrombocytopenia More	Approved
Factor VIII(Guangdong Wellen Biological Pharmaceutical Co. Ltd.) ( F10 )	Hemophilia A More	Pending